Clinical Trial: ECOG-ACRIN EAY131

ECOG-ACRIN EAY131

Status: Closed

Molecular Analysis for Therapy Choice (MATCH)

EAY131 is closed to accrual, effective 5:00pm ET on December 30, 2022.